1Kayikcioglu M, Turkoglu C, Can L, et al. The combined use of pravastatine and thrombolytic agents in acute myocardial infarction: Clinical and angiographical results. J Am Coll Cardiol, 2000,35 (Suppl A) 345A-346A.
2Maron D J, Fazio S, Linton M F. Current perspectives on statins. Circulation, 2000,101:207-213.
3Bustos C, Hernandez-Presa M A, Ortego M, et al. HMG-GoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atheroscle- rosis. J AmCollCardiol, 1998,32:2057-2064.
4Laufs U, Liao J K. Post-transcriptional regulation of endothelial nitric oxide synthasc mRNA stability by Rho GTPase. J Biol Chem, 1998,273:24266-24271.
5Williams J K, Sukova G K, Herrington D M, et al. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. J Am Coll Cardiol, 1998,31: 684-691.
6Dupuis J, Tardif J C, Cernacek P, et al. Theroux. Cholesterol reduction rapidly improves endothelial func tion of the RECIFE ( Reduction of cholesterol in ischemial and function of the endothelium ) trial. Circulation, 1999,99:3227-3233.
7Mariuca V, Stephan F, Klaudia A, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circula ion, 2001,103:2885-2890.
8Kureishi Y, Luo Z, Shiojima I, et al. The HMG-GoA reduetase inhibition simvastatin activates the protein ki nase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med, 2000,6: 1004-1010.
2Lenderink T,Boersma E,GittAK,et al. Patients using statin treatment within 24h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users:a report from the first Euro Heart Survey on acute coronary syndromes[J].Eur Heart J,2006,27(15):1799- 1803.
